PREVALENCE AND EPIDEMIOLOGIC CHARACTERISTICS OF HEPATITIS-C IN SCOTTISH BLOOD-DONORS

被引:35
作者
CRAWFORD, RJ
GILLON, J
YAP, PL
BROOKES, E
MCOMISH, F
SIMMONDS, P
DOW, BC
FOLLETT, EAC
机构
[1] EDINBURGH & SE SCOTLAND BLOOD TRANSFUS SERV,41 LAURISTON PL,EDINBURGH EH3 9HB,SCOTLAND
[2] LAW HOSP,GLASGOW & W SCOTLAND BLOOD TRANSFUS SERV,CARLUKE ML8 5ES,SCOTLAND
[3] NINEWELLS HOSP,E SCOTLAND BLOOD TRANSFUS SERV,DUNDEE DD1 9SY,SCOTLAND
[4] RUCHILL HOSP,SCOTTISH NATL BLOOD TRANSFUS SERV,MICROBIOL REFERENCE UNIT,GLASGOW G20 9NB,SCOTLAND
[5] UNIV EDINBURGH,SCH MED,DEPT MED MICROBIOL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND
关键词
D O I
10.1111/j.1365-3148.1994.tb00252.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
All blood donors in Scotland who were found to be infected with hepatitis C virus (HCV) in the first 6 months of routine testing of all donations for anti-HCV were contacted. Those who attended were counselled, a history of exposure to risk was sought, and blood was taken for alanine aminotransferase (ALT) level as a measure of liver function. The epidemiological features were then correlated with the virological findings and ALT. In the period under study between September 1991 and February 1992, 180 658 blood donors attended. The prevalence of HCV infection was 0.088%. Of the 151 donors who attended for counselling, 101 (68%) were male. Intravenous drug use was the most common risk activity (39%), followed by previous blood transfusion (15.2%), other parenteral exposure (11.2%) and heterosexual contact with a parenterally infected partner (8.6%, 29.1% of donors gave no history of possible exposure. Elevated ALT levels were found in 59%. ALT levels were higher in donors with HCV types 1 and 3 than in HCV type 2 or non-viraemic donors. The prevalence of HCV in Scottish blood donors is thus relatively low. This may relate to the effectiveness of donor selection procedures, but donors with risk activities which should debar them continue to donate. The combination of ALT and PCR appears to be useful in counselling and assessing infected donors.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 15 条
  • [1] ANTIBODY TO HEPATITIS-C VIRUS AND LIVER-DISEASE IN VOLUNTEER BLOOD-DONORS
    ALBERTI, A
    CHEMELLO, L
    CAVALLETTO, D
    TAGGER, A
    DALCANTON, A
    BIZZARO, N
    TAGARIELLO, G
    RUOL, A
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (12) : 1010 - 1012
  • [2] HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV
    ALBERTI, A
    MORSICA, G
    CHEMELLO, L
    CAVALLETTO, D
    NOVENTA, F
    PONTISSO, P
    RUOL, A
    [J]. LANCET, 1992, 340 (8821) : 697 - 698
  • [3] ENHANCED SENSITIVITY OF A 2ND GENERATION ELISA FOR ANTIBODY TO HEPATITIS-C VIRUS
    BRESTERS, D
    CUYPERS, HTM
    REESINK, HW
    SCHAASBERG, WP
    VANDERPOEL, CL
    MAUSERBUNSCHOTEN, EP
    HOUGHTON, M
    CHOO, QL
    KUO, G
    LESNIEWSKI, R
    TROONEN, H
    LELIE, PN
    [J]. VOX SANGUINIS, 1992, 62 (04) : 213 - 217
  • [4] LOW INCIDENCE OF NON-A, NON-B POSTTRANSFUSION HEPATITIS IN LONDON CONFIRMED BY HEPATITIS-C VIRUS SEROLOGY
    CONTRERAS, M
    BARBARA, JAJ
    ANDERSON, CC
    RANASINGHE, E
    MOORE, C
    BRENNAN, MT
    HOWELL, DR
    ALOYSIUS, S
    YARDUMIAN, A
    [J]. LANCET, 1991, 337 (8744) : 753 - 757
  • [5] HIGH-RATE OF INFECTIVITY AND LIVER-DISEASE IN BLOOD-DONORS WITH ANTIBODIES TO HEPATITIS-C VIRUS
    ESTEBAN, JI
    LOPEZTALAVERA, JC
    GENESCA, J
    MADOZ, P
    VILADOMIU, L
    MUNIZ, E
    MARTINVEGA, C
    ROSELL, M
    ALLENDE, H
    VIDAL, X
    GONZALEZ, A
    HERNANDEZ, JM
    ESTEBAN, R
    GUARDIA, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 443 - 449
  • [6] HEPATITIS-C VIREMIA IN UNITED-KINGDOM BLOOD-DONORS - A MULTICENTER STUDY
    GARSON, JA
    CLEWLEY, JP
    SIMMONDS, P
    ZHANG, LQ
    MORI, J
    RING, C
    FOLLETT, EAC
    DOW, BC
    MARTIN, S
    GUNSON, H
    [J]. VOX SANGUINIS, 1992, 62 (04) : 218 - 223
  • [7] DETECTION OF HEPATITIS-C VIRAL SEQUENCES IN BLOOD DONATIONS BY NESTED POLYMERASE CHAIN-REACTION AND PREDICTION OF INFECTIVITY
    GARSON, JA
    TEDDER, RS
    BRIGGS, M
    TUKE, P
    GLAZEBROOK, JA
    TRUTE, A
    PARKER, D
    BARBARA, JAJ
    CONTRERAS, M
    ALOYSIUS, S
    [J]. LANCET, 1990, 335 (8703) : 1419 - 1422
  • [8] GESINDE MO, 1992, LANCET, V339, P928
  • [9] HISTORY OF PREVIOUS DRUG MISUSE IN HCV-POSITIVE BLOOD-DONORS
    GOODRICK, MJ
    ANDERSON, NAB
    FRASER, ID
    ROUSE, A
    PEARSON, V
    [J]. LANCET, 1992, 339 (8791) : 502 - 502
  • [10] SPECIFICITY AND SENSITIVITY OF 1ST AND 2ND GENERATION ANTI-HCV ELISA IN A LOW PREVALENCE POPULATION
    KOLHO, E
    [J]. TRANSFUSION MEDICINE, 1992, 2 (03) : 239 - 242